BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 11249733)

  • 1. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-idiotype vaccine against cancer.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.
    Fernández LE; Alonso DF; Gomez DE; Vázquez AM
    Expert Rev Vaccines; 2003 Dec; 2(6):817-23. PubMed ID: 14711364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].
    Castello G; D'Alessio V
    Clin Ter; 1991 May; 137(3):155-67. PubMed ID: 1831084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts in immunotherapy for the treatment of colorectal cancer.
    Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
    J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model.
    Fuentes D; Avellanet J; Garcia A; Iglesias N; Gabri MR; Alonso DF; Vazquez AM; Perez R; Montero E
    Breast Cancer Res Treat; 2010 Apr; 120(2):379-89. PubMed ID: 19377876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotype antibodies in cancer treatment.
    de Cerio AL; Zabalegui N; Rodríguez-Calvillo M; Inogés S; Bendandi M
    Oncogene; 2007 May; 26(25):3594-602. PubMed ID: 17530013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu.
    Mohanty K; Saha A; Pal S; Mallick P; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
    Breast Cancer Res Treat; 2007 Jul; 104(1):1-11. PubMed ID: 17004107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appraisal of anti-idiotypic antibodies in the treatment of solid tumors in humans.
    Euhus DM; Wong JH
    Surg Gynecol Obstet; 1992 Jul; 175(1):89-96. PubMed ID: 1621207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
    Bhattachary-Chatterjee M; Nath Baral R; Chatterjee SK; Das R; Zeytin H; Chakraborty M; Foon KA
    Cancer Immunol Immunother; 2000 Jun; 49(3):133-41. PubMed ID: 10881692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization against tumor cell surface complement-regulatory proteins.
    Durrant LG; Spendlove I
    Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.
    Robins RA; Denton GW; Hardcastle JD; Austin EB; Baldwin RW; Durrant LG
    Cancer Res; 1991 Oct; 51(19):5425-9. PubMed ID: 1913661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies.
    Korman A; Yellin M; Keler T
    Curr Opin Investig Drugs; 2005 Jun; 6(6):582-91. PubMed ID: 15988909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mimicry of tumor-associated antigens by antiidiotypic antibodies.
    Herlyn D; Wettendorff M; Iliopoulos D; Koprowski H
    Exp Clin Immunogenet; 1988; 5(4):165-75. PubMed ID: 3078570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.